EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Clinical Significance of SDC2 in Gastric Cancer: Insights From a Multi-Center Cohort Study

Yihang Xu, Zisong Wang, Xuanyu Wang, Yuxin Chen, Jian Xu, Fan Wang, Sufang Tian, Xiaoping Liu iD

Cancer Informatics · 2026-05 · 25

DOI: 10.1177/11769351261452672 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Cancer Informatics, online erschienen am 30.05.2026. Verfasst von Yihang Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Zhongnan Hospital of Wuhan University, Hubei Province, China. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Gastric Cancer (GC) poses a significant global health challenge, necessitating effective biomarkers for early detection and prognosis. This study investigates the relationship between SDC2 expression and GC patient outcomes.

Methods

We analyzed SDC2 expression in GC and its association with patient outcomes using Kaplan-Meier survival and Cox regression analyses. A pan-cancer analysis was performed to assess cross-tumor SDC2 expression patterns. Validation included immunohistochemistry and single-cell data analyses to confirm SDC2 expression in GC tissues and cell types, with findings supported by independent cohort studies.

Results

Elevated SDC2 expression correlates with poor prognosis in GC patients, marked by lower survival rates, enhanced tumor microenvironment heterogeneity, decreased tumor mutational burden, and reduced immunotherapy efficacy. Kaplan-Meier and Cox regression analyses confirm that higher SDC2 expression is associated with shorter overall survival, establishing it as an independent prognostic risk factor. Pan-cancer analysis reveals consistent SDC2 expression patterns across multiple cancers, indicating broad clinical relevance. Validation through immunohistochemistry and single-cell data analysis confirms SDC2 expression in GC tissues and cell types. Independent cohort studies further support these findings.

Conclusion

In summary, this study underscores the potential of SDC2 as a promising target for early diagnosis and therapeutic intervention in GC, with implications for other malignancies.

Schlagwörter

Stichwörter der Autor:innen

SDC2cancer biomarkergastric cancerimmunotherapytumor microenvironment

Autor:innen und Institutionen

  • Department of Pathology, Zhongnan Hospital of Wuhan University, Hubei Province, China.
  • Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Hubei Province, China.

ORCID-Profile: Xiaoping Liu

Zitieren

APA

Xu, Y., Wang, Z., Wang, X., Chen, Y., Xu, J., Wang, F., Tian, S., & Liu, X. (2026). Clinical Significance of SDC2 in Gastric Cancer: Insights From a Multi-Center Cohort Study. Cancer Informatics, 25. https://doi.org/10.1177/11769351261452672

Vancouver

Xu Y, Wang Z, Wang X, Chen Y, Xu J, Wang F, et al. Clinical Significance of SDC2 in Gastric Cancer: Insights From a Multi-Center Cohort Study. Cancer Informatics. 2026;25. doi:10.1177/11769351261452672

BibTeX
@article{Xu2026,
  author = {Xu, Yihang and Wang, Zisong and Wang, Xuanyu and Chen, Yuxin and Xu, Jian and Wang, Fan and Tian, Sufang and Liu, Xiaoping},
  title = {Clinical Significance of SDC2 in Gastric Cancer: Insights From a Multi-Center Cohort Study},
  journal = {Cancer Informatics},
  year = {2026},
  volume = {25},
  doi = {10.1177/11769351261452672}
}
Kostenlos starten →